huahaipharm(SH:600521)2021-10-29 16:00Financial Performance - The company's revenue for Q3 2021 was approximately ¥1.56 billion, a decrease of 0.17% compared to the same period last year[4]. - Net profit attributable to shareholders for Q3 2021 was approximately ¥73.96 million, down 71.79% year-on-year[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was approximately ¥30.37 million, a decline of 87.55% compared to the previous year[4]. - The company reported a basic earnings per share of ¥0.06 for Q3 2021, a decrease of 66.67% year-on-year[5]. - Total operating revenue for the first three quarters of 2021 was ¥4,597,707,821.05, a decrease of 5.6% compared to ¥4,870,611,930.68 in the same period of 2020[16]. - Net profit for Q3 2021 was ¥594,079,162.20, down 33.1% from ¥887,035,750.65 in Q3 2020[19]. - Total profit for Q3 2021 was ¥769,196,944.53, a decrease of 28.1% from ¥1,069,067,651.80 in Q3 2020[19]. - The total comprehensive income for Q3 2021 was ¥590,541,445.18, down from ¥882,685,639.25 in Q3 2020, indicating a decline of 33.0%[20]. Assets and Liabilities - Total assets at the end of the reporting period were approximately ¥14.77 billion, an increase of 13.68% compared to the end of the previous year[5]. - The company's current assets totaled CNY 6.80 billion, up from CNY 6.52 billion year-over-year, indicating an increase of about 4.3%[13]. - Total liabilities increased to CNY 7.80 billion from CNY 6.27 billion, which is an increase of approximately 24.2%[15]. - The company's equity attributable to shareholders reached CNY 6.80 billion, up from CNY 6.51 billion, representing a growth of about 4.4%[15]. - Long-term borrowings rose to CNY 1.76 billion, compared to CNY 1.33 billion, indicating an increase of approximately 32.3%[15]. - The total non-current assets amounted to CNY 7.96 billion, up from CNY 6.47 billion, reflecting an increase of approximately 23.1%[14]. Cash Flow - The cash flow from operating activities for the year-to-date period decreased by 41.73% to approximately ¥680.74 million[7]. - The net cash flow from operating activities was CNY 680,741,615.29, compared to CNY 1,168,273,782.69 in the previous year[23]. - The net cash flow from investing activities was -CNY 1,511,070,936.81, a decrease from -CNY 999,183,762.80 year-over-year[23]. - The net cash flow from financing activities was CNY 960,393,034.23, improving from -CNY 123,823,124.56 in the previous year[23]. - The total cash and cash equivalents at the end of the period amounted to CNY 2,300,573,132.55, up from CNY 1,462,124,386.42 year-over-year[23]. Expenses and Costs - Total operating costs increased to ¥4,268,571,031.99 in Q3 2021 from ¥3,828,686,002.08 in Q3 2020, representing an increase of 11.5%[17]. - Research and development expenses rose to ¥570,006,180.69 in Q3 2021, up 50.4% from ¥379,087,834.41 in Q3 2020[17]. - The company experienced a rise in sales expenses, which amounted to ¥879,140,906.93 in Q3 2021, compared to ¥790,928,654.01 in Q3 2020, marking an increase of 11.1%[17]. - The decline in profits was primarily due to a drop in raw material prices, increased raw material costs, and rising environmental protection expenses[7]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was not specified, but the largest shareholder held 24.51% of the shares[8]. - The company’s retained earnings increased to CNY 3.47 billion from CNY 3.18 billion, showing a growth of about 9.2%[15]. Investment Income - The company reported a significant increase in investment income, reaching ¥158,598,981.02 in Q3 2021, compared to a loss of ¥20,578,396.32 in Q3 2020[17]. Cash Management - The company received CNY 2,156,707,463.00 in cash from borrowings, compared to CNY 3,755,614,424.05 in the previous year[23]. - Cash paid for the repayment of debts was CNY 1,129,404,102.33, down from CNY 3,499,260,400.00 year-over-year[23]. - The cash inflow from investment activities totaled CNY 224,890,029.59, compared to CNY 42,189,809.20 in the previous year[23]. - The cash outflow for the acquisition of fixed assets was CNY 1,687,657,116.40, an increase from CNY 901,977,072.00 year-over-year[23]. - The impact of exchange rate changes on cash and cash equivalents was -CNY 27,199,094.89, compared to -CNY 71,921,493.67 in the previous year[23].